Back to Search Start Over

Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells.

Authors :
Kryvenko V
Wessendorf M
Morty RE
Herold S
Seeger W
Vagin O
Dada LA
Sznajder JI
Vadász I
Source :
International journal of molecular sciences [Int J Mol Sci] 2020 Feb 21; Vol. 21 (4). Date of Electronic Publication: 2020 Feb 21.
Publication Year :
2020

Abstract

Alveolar edema, impaired alveolar fluid clearance, and elevated CO <subscript>2</subscript> levels (hypercapnia) are hallmarks of the acute respiratory distress syndrome (ARDS). This study investigated how hypercapnia affects maturation of the Na,K-ATPase (NKA), a key membrane transporter, and a cell adhesion molecule involved in the resolution of alveolar edema in the endoplasmic reticulum (ER). Exposure of human alveolar epithelial cells to elevated CO <subscript>2</subscript> concentrations caused a significant retention of NKA-β in the ER and, thus, decreased levels of the transporter in the Golgi apparatus. These effects were associated with a marked reduction of the plasma membrane (PM) abundance of the NKA-α/β complex as well as a decreased total and ouabain-sensitive ATPase activity. Furthermore, our study revealed that the ER-retained NKA-β subunits were only partially assembled with NKA α-subunits, which suggests that hypercapnia modifies the ER folding environment. Moreover, we observed that elevated CO <subscript>2</subscript> levels decreased intracellular ATP production and increased ER protein and, particularly, NKA-β oxidation. Treatment with α-ketoglutaric acid (α-KG), which is a metabolite that has been shown to increase ATP levels and rescue mitochondrial function in hypercapnia-exposed cells, attenuated the deleterious effects of elevated CO <subscript>2</subscript> concentrations and restored NKA PM abundance and function. Taken together, our findings provide new insights into the regulation of NKA in alveolar epithelial cells by elevated CO <subscript>2</subscript> levels, which may lead to the development of new therapeutic approaches for patients with ARDS and hypercapnia.

Details

Language :
English
ISSN :
1422-0067
Volume :
21
Issue :
4
Database :
MEDLINE
Journal :
International journal of molecular sciences
Publication Type :
Academic Journal
Accession number :
32098115
Full Text :
https://doi.org/10.3390/ijms21041467